NB
N-Zyme Biomedical
Wauwatosa, United States · $4.6M raised
- Headquarters
- Wauwatosa
- Total Funding
- $4.6M
- Last Round
- $4.6M Series AJul 2026
- Rounds
- 1
About
Reflux disease therapeutics platform
Summary
N-Zyme Biomedical is a Biotech company based in Wauwatosa, United States. It has raised $4.6M in total across 1 round, most recently a $4.6M Series A round in Jul 2026.
Funding History
$4.6M
Jul 2026
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private Equity·$5.0B·Jun 2017
Simtra BioPharma Solutions
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA
Global fertility clinics platform
Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Altos Labs
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022